ArticleMolecular cancer research : MCR2022

GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress.

Mary M Mullen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.